John Paulson’s Paulson & Co. disclosed in an SEC filing its holdings as of June 30, 2024. The fund’s one new buy during the second quarter was Everbridge (EVBG). The fund exited two positions during the quarter, namely Newmark (NMRK) and Alibaba (BABA). Paulson increased its stake in Madrigal Pharma (MDGL) and reduced its position in Anglogold (AU). The fund’s top holdings as of June 30, in order of size, were Madrigal, Brightsphere (BSIG), Bausch Health (BHC), Perpetua (PPTA), and Novagold (NG).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMRK: